Abstract
Safety and pharmacokinetics of single and repeated dose of a novel formulation of intra-nasal Oxytocin (TTA-121) in healthy Japanese volunteers (double blind, placebo-controlled Phase 1 trial)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings for Annual Meeting of The Japanese Pharmacological Society
Paper Title
Journal
Date
